Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Psychosocial Factors Affecting Bisphosphonate Adherence
EF 2008-09
Résumé
BACKGROUND: Despite effective treatments for osteoporosis, studies have shown that up to 50% of patients stop taking their medication one year after therapy, which is associated with higher fracture rates. Other negative effects on the health care system include increased amounts of unused prescription, increased visits to health care providers, unnecessary testing for treatment monitoring, excess health burden due to poor disease management, and unnecessary treatment costs. Women may stop taking their osteoporosis medication because of complex personal and behavioural characteristics, including support from family and friends and/or depression. OBJECTIVES: Therefore, the objectives of this project are to 1) identify the behavioural factors that can help explain why women stop taking their osteoporosis medications; and, 2) figure out which behavioural factors are the most important among these identified factors. PROJECT SUMMARY: A random sample will be selected from 14,163 women who originally participated in the Study of Arthritis in Your Community. Women fluent in English aged from 65-90 years will be eligible. This research focuses on women of this particular age group because they are entering the highest period of risk for fractures and treatment guidelines have only recently been published for men. CONTRIBUTION: The overall goal of this research is to reduce the burden of illness of osteoporosis and associated hip fractures in the population by examining behavioural factors related to staying on osteoporosis medications. The results of this study will be used to inform strategies to reduce the number of women stopping their osteoporosis medications.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
184360
Name
Munce Sarah E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Psychosocial Factors Affecting Bisphosphonate Adherence
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Adherence; Bisphosphonate; Osteoporosis; Psychosocial
Abstract
BACKGROUND: Despite effective treatments for osteoporosis, studies have shown that up to 50% of patients stop taking their medication one year after therapy, which is associated with higher fracture rates. Other negative effects on the health care system include increased amounts of unused prescription, increased visits to health care providers, unnecessary testing for treatment monitoring, excess health burden due to poor disease management, and unnecessary treatment costs. Women may stop taking their osteoporosis medication because of complex personal and behavioural characteristics, including support from family and friends and/or depression. OBJECTIVES: Therefore, the objectives of this project are to 1) identify the behavioural factors that can help explain why women stop taking their osteoporosis medications; and, 2) figure out which behavioural factors are the most important among these identified factors. PROJECT SUMMARY: A random sample will be selected from 14,163 women who originally participated in the Study of Arthritis in Your Community. Women fluent in English aged from 65-90 years will be eligible. This research focuses on women of this particular age group because they are entering the highest period of risk for fractures and treatment guidelines have only recently been published for men. CONTRIBUTION: The overall goal of this research is to reduce the burden of illness of osteoporosis and associated hip fractures in the population by examining behavioural factors related to staying on osteoporosis medications. The results of this study will be used to inform strategies to reduce the number of women stopping their osteoporosis medications.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Munce, Sarah E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~